Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Efficacy and Safety of an H.Pylori Vaccine in H.Pylori-Negative Adults [Phase 1]
Phase 1 trial evaluating the safety and early efficacy of a Helicobacter pylori vaccine in adults who are H. pylori-negative; results were p…
-
FDA approval · 2017-02-17FDA Approved: RABEPRAZOLE SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved an original ANDA for a generic rabeprazole sodium product from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS withdrawal · 2017-02-09Clinical Trial Update: Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori [Phase 3]
A Phase 3 trial assessing Pylera BID dosing for Helicobacter pylori eradication has been withdrawn.
-
FDA approval · 2017-01-25FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the fixed-dose combination of bismuth subcitrate potassium, metronidazole, and tetracycline hydr…
-
FDA approval · 2017-01-19FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for the Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride product from …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: ERADICATE Hp - Treating Helicobacter Pylori With RHB-105 [Phase 3]
Phase 3 trial update for ERADICATE Hp evaluating RHB-105 to treat Helicobacter pylori infection; study completed with results posted.
-
CLINICAL_TRIALS research · 2017-01-05Clinical Trial Update: Diagnosis Ability of Linked Color Imaging for Helicobacter Pylori Infection Compared With White Light Imaging
This clinical trial update evaluates the diagnostic ability of Linked Color Imaging (LCI) for Helicobacter pylori infection compared with wh…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Clinical Experiment of Helicobacter Pylori Transmission [NA]
Completed a clinical trial investigating Helicobacter pylori transmission; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication [Phase 4]
This clinical trial update reports the completion of a Phase 4 study comparing 7-day versus 14-day bismuth-based quadruple therapy for secon…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Helicobacter Pylori and Proton Pump Inhibitor
This clinical trial update notes that the study examining Helicobacter pylori infection in conjunction with a proton pump inhibitor has comp…
-
FDA approval · 2016-12-01FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) from AmerisourceBergen, updating labeling and…
-
CLINICAL_TRIALS research · 2016-11-10Clinical Trial Update: Helicobacter Pylori Antibiotic Susceptibility Testing of Korea
This clinical trial update describes a Korean study investigating antibiotic susceptibility testing for Helicobacter pylori. The conditions …
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication [NA]
A completed clinical trial evaluated levofloxacin-containing regimens as second-line therapy for Helicobacter pylori eradication, with resul…
-
CLINICAL_TRIALS research · 2016-10-26Clinical Trial Update: Difference of Gastric Microbiota in the Process of Correa's Model.
This clinical trial update examines differences in gastric microbiota during the Correa model of gastric carcinogenesis. Sponsored by Shando…
-
FDA approval · 2016-10-24FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2016-10-24FDA Approved: ESOMEPRAZOLE STRONTIUM — Supplemental Application (R2 Pharma, LLC)
The FDA approved a supplemental application to authorize the marketing of esomeprazole strontium, a salt form of esomeprazole, for use in th…
-
FDA approval · 2016-10-14FDA Approved: LANSOPRAZOLE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s generic lansoprazole under an original ANDA.
-
CLINICAL_TRIALS research · 2016-10-14Clinical Trial Update: Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection [Phase 4]
A Phase 4 clinical trial update investigating the optimal duration of antimicrobial susceptibility test-guided rescue therapy for Helicobact…
-
CLINICAL_TRIALS research · 2016-10-14Clinical Trial Update: The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study [Phase 4]
This Phase 4 prospective cohort study investigates whether eradication of Helicobacter pylori influences long-term gastric pathology, includ…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Efficacy of Short-message-based Re-education (SMRE) on Helicobacter Pylori Eradication [Phase 4]
Phase 4 trial evaluating the efficacy of short-message-based re-education (SMRE) to improve Helicobacter pylori eradication rates.
-
FDA approval · 2016-10-07FDA Approved: LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN — Original Application (Rising Pharma Holdings, Inc.)
FDA approved a new generic triple-therapy combination of lansoprazole, amoxicillin, and clarithromycin (Original Application) from Rising Ph…
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Primary Antimicrobial Resistance Patterns of Austrian Helicobacter Pylori Clinical Isolates
A clinical trial update describing antimicrobial resistance patterns of Helicobacter pylori isolates from Austria. The study status is compl…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori [NA]
This completed clinical trial evaluated whether tailoring second-line therapy for Helicobacter pylori based on antimicrobial susceptibility …
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Traditional Chinese Medicine Combined With Standard Triple Region for Eradication of Helicobacter Pylori [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluates adding Traditional Chinese Medicine to standard triple therapy for Helicobacter pylori infect…
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: Study of Levofloxacin-based Concomitant Therapy for H. Pylori Eradication in Diabetic Patients [Phase 4]
A Phase 4 clinical trial evaluating levofloxacin-based concomitant therapy for eradicating Helicobacter pylori in diabetic patients has comp…